Nobilis OR Inac

国家: 欧盟

语言: 英文

来源: EMA (European Medicines Agency)

现在购买

资料单张 资料单张 (PIL)
01-10-2022
产品特点 产品特点 (SPC)
01-10-2022
公众评估报告 公众评估报告 (PAR)
03-10-2022

有效成分:

inactivated whole cell suspension of Ornithobacterium rhinotracheale serotype A, strain B3263/91

可用日期:

Intervet International BV

ATC代码:

QI01AB07

INN(国际名称):

adjuvanted inactivated vaccine against Ornithobacterium rhinotracheale serotype A

治疗组:

Chicken

治疗领域:

Immunologicals for aves

疗效迹象:

For passive immunisation of broilers induced by active immunisation of female broiler breeders to reduce infection with Ornithobacterium rhinotracheale serotype A when this agent is involved. Under field conditions passive immunity is transferred during lay for 43 weeks after the last vaccination of broiler breeders, resulting in a duration of passive immunity in broilers of at least 14 days after hatching.,

產品總結:

Revision: 7

授权状态:

Withdrawn

授权日期:

2003-01-24

资料单张

                                Medicinal product no longer authorised
15
B. PACKAGE LEAFLET
Medicinal product no longer authorised
16
PACKAGE LEAFLET
Nobilis OR inac emulsion for injection for chickens
1.
NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF
THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH
RELEASE IN THE EEA
Marketing authorisation holder and manufacturer:
Intervet International
Wim de Körverstraat 35
5831 AN Boxmeer
The Netherlands
2.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Nobilis OR inac emulsion for injection for chickens
3.
STATEMENT OF THE ACTIVE SUBSTANCE(S) AND OTHER INGREDIENT(S)
Per dose of 0.25 ml:
Inactivated whole cell suspension of _Ornithobacterium rhinotracheale_
serotype A strain B3263/91 1 x
10
7
cells *
* inducing a mean titre in the chickens of the potency test of at
least 11.2 (log
2
).
Light liquid paraffin: 107.21 mg
Traces of formaldehyde
4.
INDICATION(S)
For passive immunisation of broilers induced by active immunisation of
female broiler breeders to
reduce infection with _Ornithobacterium rhinotracheale_ serotype A
when this agent is involved.
Under field conditions passive immunity is transferred during lay for
43 weeks after the last
vaccination of broiler breeders, resulting in a duration of passive
immunity in broilers of at least 14
days after hatching.
5.
CONTRAINDICATIONS
Do not use for birds in lay
6.
ADVERSE REACTIONS
In laboratory studies, a local transient swelling was found at post
mortem examination in up to 40% of
the birds for at least 14 days after subcutaneous vaccination. Under
field conditions, sporadic local and
systemic clinical reactions have been reported.
If you notice any serious effects or other effects not mentioned in
this leaflet, please inform your
veterinary surgeon.
Medicinal product no longer authorised
17
7.
TARGET SPECIES
Chickens
8.
DOSAGE FOR EACH SPECIES, ROUTE(S) AND METHOD OF ADMINISTRATION
Single dose of 0.25 ml.
Subcutaneous injection in the neck or intramuscular injection in the
breast of the chicken.
9.
ADVICE ON CORRECT ADMINISTRATION

                                
                                阅读完整的文件
                                
                            

产品特点

                                Medicinal product no longer authorised
1
ANNEX I
SUMMARY OF PRODUCT CHARACTERISTICS
Medicinal product no longer authorised
2
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Nobilis OR inac emulsion for injection for chickens
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Per dose of 0.25 ml:
ACTIVE SUBSTANCE
Inactivated whole cell suspension of _Ornithobacterium rhinotracheale_
serotype A, strain B3263/91 1 x
10
7
cells *
* inducing a mean titre in the chickens of the potency test of at
least 11.2 (log
2
).
ADJUVANT
Light liquid paraffin:
107.21 mg
EXCIPIENTS
Traces of formaldehyde
For a list of excipients, see section 6.1
3.
PHARMACEUTICAL FORM
Emulsion for injection
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Chickens
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For passive immunisation of broilers induced by active immunisation of
female broiler breeders to
reduce infection with _Ornithobacterium rhinotracheale_ serotype A
when this agent is involved.
Under field conditions passive immunity is transferred during lay for
43 weeks after the last
vaccination of broiler breeders, resulting in a duration of passive
immunity in broilers of at least 14
days after hatching.
4.3
CONTRAINDICATIONS
Do not use in birds in lay.
4.4
SPECIAL WARNINGS
None
Medicinal product no longer authorised
3
4.5
SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Allow vaccine to reach room temperature (15-25°C) before using the
vaccine.
Shake well before use.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
VETERINARY MEDICINAL PRODUCT TO
ANIMALS
To the user:
This product contains mineral oil. Accidental injection/self injection
may result in severe pain and
swelling, particularly if injected into a joint or finger, and in rare
cases could result in the loss of the
affected finger if prompt medical attention is not given.
If you are accidentally injected with this product, seek prompt
medical advice even if only a very
small amount is injected and take the package insert with you.
If pain persists for mo
                                
                                阅读完整的文件
                                
                            

其他语言的文件

资料单张 资料单张 保加利亚文 01-10-2022
产品特点 产品特点 保加利亚文 01-10-2022
公众评估报告 公众评估报告 保加利亚文 03-10-2022
资料单张 资料单张 西班牙文 01-10-2022
产品特点 产品特点 西班牙文 01-10-2022
公众评估报告 公众评估报告 西班牙文 03-10-2022
资料单张 资料单张 捷克文 01-10-2022
产品特点 产品特点 捷克文 01-10-2022
公众评估报告 公众评估报告 捷克文 03-10-2022
资料单张 资料单张 丹麦文 01-10-2022
产品特点 产品特点 丹麦文 01-10-2022
公众评估报告 公众评估报告 丹麦文 03-10-2022
资料单张 资料单张 德文 01-10-2022
产品特点 产品特点 德文 01-10-2022
公众评估报告 公众评估报告 德文 03-10-2022
资料单张 资料单张 爱沙尼亚文 01-10-2022
产品特点 产品特点 爱沙尼亚文 01-10-2022
公众评估报告 公众评估报告 爱沙尼亚文 03-10-2022
资料单张 资料单张 希腊文 01-10-2022
产品特点 产品特点 希腊文 01-10-2022
公众评估报告 公众评估报告 希腊文 03-10-2022
资料单张 资料单张 法文 01-10-2022
产品特点 产品特点 法文 01-10-2022
公众评估报告 公众评估报告 法文 03-10-2022
资料单张 资料单张 意大利文 01-10-2022
产品特点 产品特点 意大利文 01-10-2022
公众评估报告 公众评估报告 意大利文 03-10-2022
资料单张 资料单张 拉脱维亚文 01-10-2022
产品特点 产品特点 拉脱维亚文 01-10-2022
公众评估报告 公众评估报告 拉脱维亚文 03-10-2022
资料单张 资料单张 立陶宛文 01-10-2022
产品特点 产品特点 立陶宛文 01-10-2022
公众评估报告 公众评估报告 立陶宛文 03-10-2022
资料单张 资料单张 匈牙利文 01-10-2022
产品特点 产品特点 匈牙利文 01-10-2022
公众评估报告 公众评估报告 匈牙利文 03-10-2022
资料单张 资料单张 马耳他文 01-10-2022
产品特点 产品特点 马耳他文 01-10-2022
公众评估报告 公众评估报告 马耳他文 03-10-2022
资料单张 资料单张 荷兰文 01-10-2022
产品特点 产品特点 荷兰文 01-10-2022
公众评估报告 公众评估报告 荷兰文 03-10-2022
资料单张 资料单张 波兰文 01-10-2022
产品特点 产品特点 波兰文 01-10-2022
公众评估报告 公众评估报告 波兰文 03-10-2022
资料单张 资料单张 葡萄牙文 01-10-2022
产品特点 产品特点 葡萄牙文 01-10-2022
公众评估报告 公众评估报告 葡萄牙文 03-10-2022
资料单张 资料单张 罗马尼亚文 01-10-2022
产品特点 产品特点 罗马尼亚文 01-10-2022
公众评估报告 公众评估报告 罗马尼亚文 03-10-2022
资料单张 资料单张 斯洛伐克文 01-10-2022
产品特点 产品特点 斯洛伐克文 01-10-2022
公众评估报告 公众评估报告 斯洛伐克文 03-10-2022
资料单张 资料单张 斯洛文尼亚文 01-10-2022
产品特点 产品特点 斯洛文尼亚文 01-10-2022
公众评估报告 公众评估报告 斯洛文尼亚文 03-10-2022
资料单张 资料单张 芬兰文 01-10-2022
产品特点 产品特点 芬兰文 01-10-2022
公众评估报告 公众评估报告 芬兰文 03-10-2022
资料单张 资料单张 瑞典文 01-10-2022
产品特点 产品特点 瑞典文 01-10-2022
公众评估报告 公众评估报告 瑞典文 03-10-2022